myeloid


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to myeloid: erythroid, lymphoid, myeloid leukemia, myeloid metaplasia, Myeloid cells, myeloid sarcoma

my·e·loid

 (mī′ə-loid′)
adj.
1. Of, relating to, or derived from the bone marrow.
2. Of or relating to certain blood cells, including granulocytes, monocytes, and sometimes erythrocytes and platelets but excluding lymphocytes, that are thought to derive from a common progenitor in the bone marrow.
3. Of or relating to the spinal cord.

myeloid

(ˈmaɪɪˌlɔɪd) or

myelogenous

adj
(Anatomy) of or relating to the spinal cord or the bone marrow

my•e•loid

(ˈmaɪ əˌlɔɪd)

adj.
1. pertaining to the spinal cord.
2. pertaining to or resembling bone marrow.
[1855–60]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.myeloid - of or relating to bone marrow
2.myeloid - of or relating to the spinal cord
Translations

my·e·loid

n. mieloide;
a. rel. a la médula espinal o similar a la médula espinal o a la médula ósea;
___ tissuemédula roja.
References in periodicals archive ?
Tokyo: 4503), today announced that updated data from the Phase 1/2 CHRYSALIS trial evaluating the safety, tolerability and antileukemic activity of gilteritinib (ASP2215), an orally-administered inhibitor of FLT3/AXL in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML), were presented during an oral scientific session at the American Society of Hematology (ASH) 2015 annual meeting in Orlando.
New market research titled "EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast to 2024" provides an overview of the risk factors and global trends of AML in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan).
Myeloid sarcoma, also known as chloroma, extramedullary myeloid tumor or granulocytic sarcoma, is an extramedullary tumor mass consisting of immature myeloid cells and/or myeloblasts.
His doctor did a blood test and discovered Mark had chronic myeloid leukaemia.
Iclusig, developed by company Ariad, treats aggressive forms of chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia.
A new research report suggests that the drug may have significant anti-cancer properties as they interfere with the function of myeloid derived suppressor cell that is known to reduce the body's ability to fight tumors by interfering with the activity of cells.
Previous nomenclature for myeloid sarcoma included granulocytic sarcoma, myeloblastoma, extramedullary myeloid tumor, and chloroma.
Myeloid sarcoma is an extramedullary mass of immature myeloid cells that can be associated with acute and chronic myeloid leukemia.
The drug is an intravenous formulation of decitabine (generic name) used in the treatment of myelodysplastic syndrome (MDS), in which ineffective or abnormal production of the myeloid class of blood cells occurs, and in the treatment of acute myeloid leukemia (AML).
Myeloid sarcoma is defined as a tumor mass of myeloblasts or immature myeloid cells involving an extramedullary anatomic site (1) and can occur in 3% to 8% of patients with acute myeloid leukemia (AML).
The event focused in particular on two forms of the disorder A[degrees] Myelofibrosis and Chronic Myeloid Leukemia A[degrees] which are often identiA[degrees] fied by enlargement of the spleen or liver, unexpected bruising, easy bleeding, bone pain, fatigue and weakness.
Chronic Myeloid Leukemia is often identified by enlargement of the spleen or liver, unexpected bruising, easy bleeding, bone pain, fatigue and weakness.